These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35525539)

  • 1. Purification, crystallization and drug screening of the IRAK pseudokinases.
    Lange SM; Kulathu Y
    Methods Enzymol; 2022; 667():101-121. PubMed ID: 35525539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimeric Structure of the Pseudokinase IRAK3 Suggests an Allosteric Mechanism for Negative Regulation.
    Lange SM; Nelen MI; Cohen P; Kulathu Y
    Structure; 2021 Mar; 29(3):238-251.e4. PubMed ID: 33238146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling.
    Flannery S; Bowie AG
    Biochem Pharmacol; 2010 Dec; 80(12):1981-91. PubMed ID: 20599782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulations and roles of the interleukin-1 receptor associated kinases (IRAKs) in innate and adaptive immunity.
    Gan L; Li L
    Immunol Res; 2006; 35(3):295-302. PubMed ID: 17172653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1 receptor-associated kinase family proteins: An overview of their role in liver disease.
    Wang ZY; Gao ST; Gou XJ; Qiu FR; Feng Q
    Eur J Pharmacol; 2024 Sep; 978():176773. PubMed ID: 38936453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy.
    Singer JW; Fleischman A; Al-Fayoumi S; Mascarenhas JO; Yu Q; Agarwal A
    Oncotarget; 2018 Sep; 9(70):33416-33439. PubMed ID: 30279971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling.
    Kawagoe T; Sato S; Jung A; Yamamoto M; Matsui K; Kato H; Uematsu S; Takeuchi O; Akira S
    J Exp Med; 2007 May; 204(5):1013-24. PubMed ID: 17485511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4.
    Suzuki N; Suzuki S; Duncan GS; Millar DG; Wada T; Mirtsos C; Takada H; Wakeham A; Itie A; Li S; Penninger JM; Wesche H; Ohashi PS; Mak TW; Yeh WC
    Nature; 2002 Apr; 416(6882):750-6. PubMed ID: 11923871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies.
    Bennett J; Starczynowski DT
    Curr Opin Hematol; 2022 Jan; 29(1):8-19. PubMed ID: 34743084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IRAK signalling in cancer.
    Rhyasen GW; Starczynowski DT
    Br J Cancer; 2015 Jan; 112(2):232-7. PubMed ID: 25290089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of TYK2 pseudokinase domain stabilizers that allosterically inhibit TYK2 signaling.
    Locke GA; Muckelbauer J; Tokarski JS; Barbieri CM; Belić S; Falk B; Tredup J; Wang YK
    Methods Enzymol; 2022; 667():685-727. PubMed ID: 35525559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members.
    Janssens S; Beyaert R
    Mol Cell; 2003 Feb; 11(2):293-302. PubMed ID: 12620219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IRAK-4 as the central TIR signaling mediator in innate immunity.
    Suzuki N; Suzuki S; Yeh WC
    Trends Immunol; 2002 Oct; 23(10):503-6. PubMed ID: 12297423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation and role of interleukin-1 receptor associated kinase-M in innate immunity signaling.
    Su J; Xie Q; Wilson I; Li L
    Cell Signal; 2007 Jul; 19(7):1596-601. PubMed ID: 17379480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of the interleukin-1 receptor-associated kinases (IRAKs) in cellular signaling networks controlling inflammation.
    Ringwood L; Li L
    Cytokine; 2008 Apr; 42(1):1-7. PubMed ID: 18249132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRAK-M is a negative regulator of Toll-like receptor signaling.
    Kobayashi K; Hernandez LD; Galán JE; Janeway CA; Medzhitov R; Flavell RA
    Cell; 2002 Jul; 110(2):191-202. PubMed ID: 12150927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A central role for the Hsp90.Cdc37 molecular chaperone module in interleukin-1 receptor-associated-kinase-dependent signaling by toll-like receptors.
    De Nardo D; Masendycz P; Ho S; Cross M; Fleetwood AJ; Reynolds EC; Hamilton JA; Scholz GM
    J Biol Chem; 2005 Mar; 280(11):9813-22. PubMed ID: 15647277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-13 dampens human airway epithelial innate immunity through induction of IL-1 receptor-associated kinase M.
    Wu Q; Jiang D; Smith S; Thaikoottathil J; Martin RJ; Bowler RP; Chu HW
    J Allergy Clin Immunol; 2012 Mar; 129(3):825-833.e2. PubMed ID: 22154382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular evolution and structural features of IRAK family members.
    Gosu V; Basith S; Durai P; Choi S
    PLoS One; 2012; 7(11):e49771. PubMed ID: 23166766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IRAK family in inflammatory autoimmune diseases.
    Su LC; Xu WD; Huang AF
    Autoimmun Rev; 2020 Mar; 19(3):102461. PubMed ID: 31917263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.